Comments for The Rider is Back on the MCLN Horse, But Will It Run? at http://www.biomedreports.com , comment 1 to 11 out of 11 comments http://www.biomedreports.com Wed, 08 Feb 2012 18:01:10 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1654 this is merely a test to see if I can post here in the future - testing only Fri, 04 Dec 2009 07:32:54 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1651 Why is there no message board on Yahoo? Who is screening these "posts" ? Please post criteria for vetting this board, only interested in confirming all "points of view" are being offered? CD - carl disotell Thu, 03 Dec 2009 13:07:18 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1650 Is this part of the "Manatuck" spin-off? Not sure yet what is going on? Q What is the float ? MedClean Technologies Announces Results Of Private Exchange Offer - Quick Facts (RTTNews) - Wednesday, MedClean Technologies Inc. (MCLN.OB) announced results of its private offer to exchange all of its existing Common Stock Purchase Warrants with Initial Exercise Dates between July 11, 2008 and August 29, 2008. The exchange is for newly issued Common Stock Purchase Warrants with a new lower exercise price of $0.0075 per share, exercisable for one-half the original number of shares of its common stock, par value $0.0001 per share and without a cashless exercise right. The company noted that as of the expiration time, it received Existing Warrants for exchange representing 334.8 million shares of common stock, a 92% success rate for the offer to exchange. MedClean Technologies Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. For comments and feedback: contact editorial@rttnews.com - carl disotell Thu, 03 Dec 2009 12:56:25 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1649 According to what I see on their Schedule 13D/A filing, they (Mantuck) have 135 million shares as of 11/9 and over the last few days have sold ~60 million including over 10 million yesterday (most recent filing). - Fletcher Davis Thu, 03 Dec 2009 08:50:25 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1648 According to their SEC filing, Manatuck has exercised all of their current warrants, not to say their isn't more in the future. This held up nicely, even with large blocks of selling action. The reason they sold Monday says a lot. It takes time to file the appropriate paper work with the SEC. Manatuck is simply shoring up their books, as apposed to worry about getting the best sale price. Look for a nice continued consolidation period tomorrow. If we finish well into the 4's this thing is set for a substantial, and sustainable move up in the next few weeks. - David Gunning Thu, 03 Dec 2009 08:45:19 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1647 You have become a pumper site now. - Kenzi Thu, 03 Dec 2009 07:50:43 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1645 It would explain some of the crazy selling and pps action, but it appears to have stabilized for now. Is MCLN all hype and speculative right now or are there legit short term news or catalysts to look forward to??? Thats the question. I am currently holding my position, adding on any big dips. - Matt D. Thu, 03 Dec 2009 05:36:14 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1644 I must give credit where credit is due. I never thought MCLN would get back to .04, much less break it. Grats BMR! (To try and make up for my doubt... VVUS has shown some nice action over the past three days. Three Rising Soldiers candle pattern on increasing volume. A Friday increase in volume if substantial may mean something for Monday, or not. In my wildest fantasy I would be hoping for a buy out announcement... but it probably means nothing more than a position being taken :) - Robert Thu, 03 Dec 2009 04:21:41 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1643 I have another concern about MCLN. A large part of their success would depend on the contract with MedAssests. A visit to the MedAsset web site shows no mention of a relationship to MCLN. Even an advanced search of the site does not show any results for either MCLN or a more generic regulated waste disposal. I do not see how MCLN will benefit from a relationship with MedAssets if MedAssets does not promote the relationship in any way. - Ray Buccino Thu, 03 Dec 2009 00:56:12 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1642 Why didn't Mantuck Partners sell any interest in MCLN on the 30th, when the prices were high ?. Why wait until 1st or 2nd and get a bad price ?. - santosh Subramaniam Thu, 03 Dec 2009 00:16:04 +0100 http://www.biomedreports.com/2009120320136/the-rider-is-back-on-the-mcln-horse-but-will-it-run.html#comment-1639 Manatuck, itself, is a relic left over from an era of excessive greed. Although it is likely they were simply relieving themselves of an extremely risky position in MCLN, they still have a substantial position. If this company grows a strong pair of legs, Manatuck will find themselves holding on to a gold mine they won't soon let go of. - David Gunning Wed, 02 Dec 2009 21:28:45 +0100